Report Filter Reset All
Sort By Price
Published Date
Category
Publishers
Report Type
Continents
Regions
Biliary Atresia - Market Insights, Epidemiology, and Market Forecast - 2030
DelveInsight’s ‘Biliary Atresia– Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the Biliary Atresia, h...
$6,950.00 07 September, 2020 | DelveInsight
Biliary Atresia - Market Insights, Epidemiology, and Market Forecast - 2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Biliary Atresia– Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the Biliary ...
Complement 3 Glomerulopathy (C3G) - Market Insights, Epidemiology and Market Forecast– 2030
DelveInsight’s ‘Complement 3 Glomerulopathy (C3G) - Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the...
$6,950.00 07 September, 2020 | DelveInsight
Complement 3 Glomerulopathy (C3G) - Market Insights, Epidemiology and Market Forecast– 2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Complement 3 Glomerulopathy (C3G) - Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understand...
Cutaneous T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030
DelveInsight’s ‘Cutaneous T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030’ report, delivers an in-depth understanding of the diseas...
$6,950.00 07 September, 2020 | DelveInsight
Cutaneous T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Cutaneous T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030’ report, delivers an in-depth understanding of ...
Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2030
DelveInsight’s ‘Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2030’ report deliver an in-depth understanding of the disease, histo...
$6,950.00 07 September, 2020 | DelveInsight
Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast – 2030’ report deliver an in-depth understanding of the dise...
Gastroparesis—Market Insights, Epidemiology and Market Forecast–2030
DelveInsight’s ‘Gastroparesis—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the Gastroparesis, histori...
$6,950.00 07 September, 2020 | DelveInsight
Gastroparesis—Market Insights, Epidemiology and Market Forecast–2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Gastroparesis—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the Gastroparesi...
Glioblastoma Multiforme (GBM) - Market Insights, Epidemiology and Market Forecast– 2030
DelveInsight’s ‘Glioblastoma Multiforme (GBM) - Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the Gli...
$6,950.00 07 September, 2020 | DelveInsight
Glioblastoma Multiforme (GBM) - Market Insights, Epidemiology and Market Forecast– 2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Glioblastoma Multiforme (GBM) - Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding ...
DelveInsight’s ‘Hereditary Transthyretin Amyloidosis (hATTR)- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2030’ report delivers ...
$6,950.00 07 September, 2020 | DelveInsight
Hereditary Transthyretin Amyloidosis (hATTR)- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Hereditary Transthyretin Amyloidosis (hATTR)- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2030’ report...
Hypofibrinogenemia - Market Insights, Epidemiology, and Market Forecast - 2030
DelveInsight’s ‘Hypofibrinogenemia – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Hypofibrinogene...
$6,950.00 07 September, 2020 | DelveInsight
Hypofibrinogenemia - Market Insights, Epidemiology, and Market Forecast - 2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Hypofibrinogenemia – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Hypof...
Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030
DelveInsight’s ‘Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding ...
$6,950.00 07 September, 2020 | DelveInsight
Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth unde...
Pemphigus Vulgaris (PV)-Market Insights, Epidemiology, and Market Forecast–2030
DelveInsight’s ‘Pemphigus Vulgaris (PV)-Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the PV, historic...
$6,950.00 07 September, 2020 | DelveInsight
Pemphigus Vulgaris (PV)-Market Insights, Epidemiology, and Market Forecast–2030
$6,950.00 | 07 September, 2020 | DelveInsight
DelveInsight’s ‘Pemphigus Vulgaris (PV)-Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the PV...
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
